Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless?-Reference-Cited by-同舟云学术

Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless?

Published:2017-03-09 Issue:7 Volume:58 Page:1180.2-1182
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Adams Hugo J.A.,Kwee Thomas C.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference30 articles.

1. Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis;Adams;Crit Rev Oncol Hematol.,2016

2. Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review;Adams;Ann Hematol.,2016

3. Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?;Adams;Pediatr Hematol Oncol.,2016

4. Andre MP Girinsky T Federico M . Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial. J Clin Oncol. 2017:JCO2016686394.

5. Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor DNA in Hodgkin lymphoma;Annals of Hematology;2022-09-08

2. SUVmax-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin’s lymphoma;Leukemia & Lymphoma;2020-12-08